Fulcrum Therapeutics Inc. (NASDAQ:FULC)

  • A price alert has been triggered for this video.
FULC Weekly Chart

Old Forum Content for FULC

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • oldmaratom: $FULC # H C Wainwright PT $14 after FDA releases hold on Fulcrum6058 for cycle cell
  • numbers: $SVMK - ATH - got beaten down 2 days ago, $FULC - ATH - low volume biotech, $CCC - out from squeeze not strong health care analytics
  • issues: @Trendrider $sage The others are: The analyst Matthew Harrison has the following ratings and price targets for the stocks under his coverage: Bullish Amgen, Inc. (NASDAQ: $AMGN): Overweight, $280 price target Vertex Pharmaceuticals Incorporated (NASDAQ: $VRTX): Overweight/$250 Alector Inc (NASDAQ: $ALEC): Overweight/$27 Fulcrum Therapeutics Inc (NASDAQ: $FULC): Overweight/$29 Sarepta Therapeutics Inc (NASDAQ: $SRPT): Overweight/$160 SAGE Therapeutics Inc (NASDAQ: $SAGE): Overweight/$125 Radius Health Inc (NASDAQ: $RDUS): Overweight/$36 Ultragenyx Pharmaceutical Inc (NASDAQ: $RARE): Overweight/lowered the price target from $76 to $73
  • bRobert: @issues $sage $AMGN $VRTX $ALEC $FULC $SRPT $SAGE $RDUS $RARE $AMGN has been my single stock horse Big cap Larger portfolio VERY bullish chart for a while $255 target 1
Visit the Trading Forum to join in the discussion.
Stock Price $USD 5.37
Change -0.74%
Volume 537,283

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. It has developed a proprietary product engine that employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle-wasting disorder that leads to physical impairments and disability.

Request Video of FULC
Already a member? Sign in here.

Earnings

  • May 13th, 2025 - 2025 Q1 Earnings
  • July 31st, 2025 - 2025 Q2 Earnings
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 14 day FREE membership. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 14 day, no questions asked, 100% money back guarantee!